Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation Of Changes In Mammographic Breast Density Associated With Bazedoxifene Acetate/Conjugated Estrogens, Raloxifene And Placebo In Postmenopausal Women: An Ancillary Study Of Protocol 3115A1-303-WW

NCT00774267 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00774267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00774267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation Of Changes In Mammographic Breast Density Associated With Bazedoxifene Acetate/Conjugated Estrogens, Raloxifene And Placebo In Postmenopausal Women: An Ancillary Study Of Protocol 3115A1-303-WW
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
April 30, 2010
Enrollment
507 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis